Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6153183A · kind A · utility
8Cited by
10References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 1994 |
| Grant date | Nov 28, 2000 |
| Priority date | — |
| Expiry date | Feb 4, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally co-administered with a other colony stimulating factors (CSF), cytokines, lymphokines, interleukins, hematopoietic growth factors or IL-3 variants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.